US regulators look at inhaled insulin for diabetics

A US government advisory committee is scrutinising an inhaled form of insulin that is designed to help millions of people with diabetes who now rely on injections to control their blood sugar.

Chief concerns about the drug involve its long-term effects on the lungs, as well as whether it is safe and effective for people who smoke or have lung disease, according to documents released by the US Food and Drug Administration.